2019 Speakers

Gini Deshpande CEO & Founder NuMedii
Michael G. Frank Director, World Wide R&D Strategy Pfizer
Harry Glorikian General Partner New Ventures Funds MoneyBall Medicine: Thriving in the New Data-Driven Healthcare Market
Joseph Lehar VP of Data Science, Oncology The Janssen Pharmaceutical Companies of Johnson & Johnson

2018 speakers included

Ed Addison CEO Cloud Pharmaceuticals
Ron Alfa, MD, Ph.D Vice President, Discovery & Product Recursion Pharmaceuticals
Mohammed Ali Global Head Digital Trials- Global Clinical Operations Boehringer Ingelheim Pharmaceuticals, Inc.
Alex Aronov, Ph.D. Senior Director and Head, Enterprise Data Science Vertex Pharmaceuticals
Shrujal Baxi, MD, MPH Medical Director Flatiron Health
Barun Bhhatarai, Ph.D. Investigator, PK Sciences Novartis Institutes for BioMedical Research
Wout Brusselaers CEO and Co-founder DEEP 6 AI
Elena Diez Cecilia, Ph.D. Scientific Advisor & Head of Commercialization A2A Pharmaceuticals
Pravin R. Chaturvedi, Ph.D. Board Chairman Cellanyx, Inc.
Pablo Cingolani Principal Scientist, BioInformatics & AI AstraZeneca
Marisa Co Vice President R&D Business Insights & Analytics Bristol-Myers Squibb
Paul Courtney Technical Lead, Life Sciences Tamr, Inc.
Wayne R. Danter, MD Founder and CSO 123Genetix
Nataraj Dasgupta VP, Advanced Analytics & Data Science RxDataScience, Inc.
Ronald Dorenbos, Ph.D. Associate Director – Materials & Innovation Takeda Pharmaceuticals
Nicholas Drago Assistant Director of Regulatory Policy & Intelligence Bayer Pharmaceuticals
Sean Ekins, Ph.D., D.Sc. CEO and Founder Collaborations Pharmaceuticals, Inc.
Henry "Skip" Francis, M.D. Director for Data Mining and Informatics Evaluation and Research
Office of Translational Sciences
Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA)
Harry Glorikian General Partner New Ventures Funds MoneyBall Medicine: Thriving in the New Data-Driven Healthcare Market
Tim Guilliams, Ph.D. Co-Founder & Chief Executive Officer Healx Ltd.
Cornelis “Marcel” Hop Senior Director, Drug and Pharmacokinetics Genentech
Rashan Jibowu VP Product Management tellic
Dr. Milind Kamkolkar Former Chief Data Officer Sanofi
Guido Lanza CEO Numerate
Alan S Louie, Ph.D. Research Director, Life Sciences IDC Health Insights
Kimberly Alba McCord, PhDc Basel Institute for Clinical Epidemiology and Biostatistics University of Basel, Switzerland
Travis A. McCready President & CEO Massachusetts Life Sciences Center
Gabriel Musso, Ph.D. Chief Scientific Officer BioSymetrics Inc.
Nitin Naik Vice President-Global Life Sciences, Transformational Health Frost & Sullivan
Niven R. Narain Ph.D. Co-Founder, President & CEO BERG
Jennifer K. Pai, ScD Director of Data Sciences, Strategy, and Platforms Merck & Co., Inc.
Leila Pirhaji, Ph.D. Founder and CEO ReviveMed
Andrew A. Radin CEO & Co-Founder twoXAR
Richard M. Soll, Ph.D. Senior Advisor, Strategic Initiatives WuXi AppTec
Dr. Gunaretnam (Guna) Rajagopal VP Global Head – Computational Sciences, Discovery Sciences Janssen Research & Development, A Johnson & Johnson Company
Sotirios G. Stergiopoulos, MD Chief Medical Officer and Senior Vice President Ipsen BioSciences
Joseph Szustakowski, Ph.D. Executive Director, Head, Translational Bioinformatics Bristol-Myers Squibb
Mike Townsend Research Manager, Life Sciences Commercial Strategies IDC Health Insights
W. Patrick Walters, Ph.D. VP Computation Relay Therapeutics
Adam West Director, Research Data Sciences and Engineering Eli Lilly and Company
David Wild, Ph.D. Founder & President Data2Discovery Inc
Lihua Yu, Ph.D. President, Chief Data Science Officer H3 Biomedicine Inc.
Alex Zhavoronkov, Ph.D. CEO Insilico Medicine, Inc